Cardiovascular disease (heart failure, coronary heart disease, disorders of conductance and rhythm, valvular heart diseases) I50 I20 I21 I22 I23 I24 I25 I48 I49 I05 I06 I07 I08 I34 I35 I36 I37
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Intervention group: patients with cardiovascular diseases who participate in the program and require actual treatment with a participating cardiologist. Control group: patients with cardiovascular diseases who do not participate in the program and require actual treatment with a (non-participating) cardiologist in regular healthcare. Observation period: Patient data from the period 1.1.2014 to 31.12.2016 are used for the retrospective analysis.
Exclusion criteria
Exclusion criteria: •not continuously insured with the SHI throughout 2014-2016 (except deaths in 2015-2016) •younger than 18 years at 01/01/2015 •participating in a different innovative healthcare program (in 2014-2016) •patient living outside of Baden-Wurttemberg according to postal code •cardiologist’s practice outside Baden-Wurttemberg according to postal code (in 2014)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multiple indicators of healthcare quality (utilization, pharmacotherapy, medical outcomes) and health economic analyses | — |
Countries
Germany